Cell and gene therapies gain streamlined fda oversight

被引：0

|

作者：

Wechsler, Jill

机构：

来源：

Pharmaceutical Technology | 2019年 / 43卷 / 03期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

2

引用

收藏

页码：8 / 9

相关论文

共 50 条

[41] FDA enhances oversight of postmarket drug safety
Reactions Weekly, 2012, 1400 (1) : 2 - 2
[42] Edible Cannabis Products: It Is Time for FDA Oversight
Benjamin, David M.
Fossler, Michael J.
JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (09): : 1045 - 1047
[43] Texas legitimizes path around FDA oversight
Laura DeFrancesco
Nature Biotechnology, 2012, 30 : 379 - 379
[44] FDA's Framework for Regulatory Oversight of LDTs
Pathak, Bhagyashri
Terry, Sharon F.
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2014, 18 (12) : 785 - 786
[45] FDA bioproduct oversight shifts to drug division
Wong, JF
GENETIC ENGINEERING NEWS, 2002, 22 (17): : 55 - +
[46] Outsourcing challenges FDA to strengthen oversight abroad
Torres, Christian
NATURE MEDICINE, 2010, 16 (02) : 139 - 139
[47] Texas legitimizes path around FDA oversight
DeFrancesco, Laura
NATURE BIOTECHNOLOGY, 2012, 30 (05) : 379 - 379
[48] Pandemic Alters FDA Inspections and Quality Oversight
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2021, 34 (11) : 8 - 9
[49] FDA issues oversight rules for medicated feed
Cima, Greg
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2015, 247 (02): : 129 - 129
[50] FDA Realigns Drug Inspection and Manufacturing Oversight
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2014, 27 (12) : 8 - +

← 1 2 3 4 5 →